Chiltern is a full-service, global contract research organization, with experience in the management of Phase I-IV clinical trials across a range of therapeutic areas. The company also offers functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries and offers services in early phase, global clinical development, late phase, biometrics, medical and regulatory affairs and resourcing solutions. Chiltern recently has been acquired by LabCorp.